Related Experiment Video
Updated: Dec 21, 2025

Author Spotlight: Advancing Immune Monitoring in Critical Care Patients Using Whole Blood Assays
Published on: September 20, 2024
COVID-19 in adults: test menu for hospital blood science laboratories
Paula M O'Shea1, Graham Robert Lee2, Tomás P Griffin3
1Department of Clinical Biochemistry, Saolta University Health Care Group (SUHCG), Galway University Hospitals, Newcastle Road, Galway, Ireland. PaulaM.OShea@hse.ie.
Insights
This study outlines a clinical blood sciences laboratory testing protocol for managing coronavirus disease 2019 (COVID-19). Regular monitoring of key blood parameters is crucial for effective patient management and prognostication of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.
Area of Science:
- Clinical Laboratory Science
- Infectious Disease Diagnostics
- Biochemistry and Hematology
Background:
- Coronavirus disease 2019 (COVID-19) is a significant global health concern caused by SARS-CoV-2.
- The Clinical Blood Sciences Laboratory (CBSL) is integral to patient care for COVID-19.
- Effective laboratory support is vital for managing SARS-CoV-2 infections.
Purpose of the Study:
- To establish a comprehensive testing protocol for CBSL in the context of COVID-19.
- To guide the medical management of patients infected with SARS-CoV-2.
- To standardize laboratory approaches for COVID-19 patient assessment.
Main Methods:
- Detailed description of biochemical assays relevant to COVID-19.
- Explanation of haematological tests for monitoring COVID-19 patients.
- Outline of immunological investigations utilized in SARS-CoV-2 infection.
Main Results:
- A defined test menu is provided for clinical laboratories.
- The menu facilitates effective monitoring of COVID-19 patients.
- The protocol aids in the management and prognostication of hospitalized COVID-19 cases.
Conclusions:
- Rapid deterioration is a characteristic of severe COVID-19.
- Regular laboratory testing is recommended for vigilance.
- Monitoring the rate and trajectory of change in key parameters is essential for patient outcomes.
Introduction:
Coronavirus disease 2019 (COVID-19), is a respiratory illness caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The Clinical Blood Sciences Laboratory (CBSL) plays a key role in supporting the monitoring and management of patients with COVID-19 disease.
Objective:
To provide a comprehensive CBSL testing protocol to support the medical management of SARS-CoV-2 infection.
Methods:
Description of the biochemical, haematological and immunological tests that have a role in the assessment and monitoring of patients with COVID-19 infection.
Results:
We provide a test menu for clinical laboratories to ensure the effective monitoring, management and prognostication of COVID-19 patients in hospital.
Conclusion:
Given the rapidity with which patients with COVID-19 disease can deteriorate, we recommend regular testing with vigilance paid to the rate and trajectory of change in each of these parameters.
Related Concept Videos
Serum Laboratory Studies, Stool Test, Breath Test
Blood Transfusion
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...

